Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Nucl Cardiol. 2018 May 7;25(6):2148–2158. doi: 10.1007/s12350-018-1293-9

Fig. 7.

Fig. 7

Demonstrates CMR findings in a case of acute fulminant myocarditis in a patient with metastatic melanoma shortly after receiving his first cycle of Ipilimumab/Nivolumab. (A–B) Native T1-mapping and T2 mapping respectively demonstrating elevated signals along the inferior wall consistent with myocardial edema. LGE imaging (C–D) demonstrate LGE present in the subepicardial mid inferior wall consistent with acute myocarditis.